Provided by Tiger Trade Technology Pte. Ltd.

Veracyte

30.01
-2.7900-8.51%
Post-market: 30.010.00000.00%19:32 EDT
Volume:1.50M
Turnover:45.47M
Market Cap:2.38B
PE:36.60
High:32.68
Open:32.39
Low:29.46
Close:32.80
52wk High:50.71
52wk Low:22.61
Shares:79.46M
Float Shares:78.23M
Volume Ratio:1.13
T/O Rate:1.92%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.8200
EPS(LYR):0.8200
ROE:5.34%
ROA:2.91%
PB:1.82
PE(LYR):36.60

Loading ...

Veracyte reports Q4 EPS 51c, consensus 41c

TIPRANKS
·
Feb 26

Veracyte Q4 revenue rises 19%, beats expectations

Reuters
·
Feb 26

Veracyte Q4 GAAP net income jumps 8.1x to USD 41.1 million

Reuters
·
Feb 26

BRIEF-Veracyte Q4 Revenue USD 140.6 Million Vs. IBES Estimate USD 133.6 Million

Reuters
·
Feb 26

Veracyte Outlook FY Revenue Growth 10-13%

THOMSON REUTERS
·
Feb 26

Veracyte Q4 EPS USD 0.51

THOMSON REUTERS
·
Feb 26

U.S. Earnings Preview: After Market Close Feb. 25

Dow Jones
·
Feb 26

Veracyte to Showcase Decipher and TrueMRD Data at 2026 ASCO GU Symposium

Reuters
·
Feb 24

How Investors May Respond To Veracyte (VCYT) Strong Q4 Pricing Mix And UBS Rating Reaffirmation

Simply Wall St.
·
Feb 17

Veracyte Inc. kündigt Veröffentlichung neuer Finanzergebnisse an

Reuters
·
Feb 05

Press Release: Veracyte to Release Fourth Quarter and Full-Year 2025 Financial Results on February 25, 2026

Dow Jones
·
Feb 05

Exploring US High Growth Tech Stocks In February 2026

Simply Wall St.
·
Feb 03

Assessing Veracyte (VCYT) Valuation As Recent Momentum Meets An Expensive P/E Ratio

Simply Wall St.
·
Jan 22

A Look At Veracyte (VCYT) Valuation After Strong 2025 Update And 2026 Growth Guidance

Simply Wall St.
·
Jan 14

Veracyte: Strong Near-Term Performance but Execution and Valuation Risks Justify Sell Rating

TIPRANKS
·
Jan 13

Veracyte reports preliminary Q4 revenue $138M-$140M, consensus $131.75M

TIPRANKS
·
Jan 12

Veracyte sees FY26 revenue $570M-$582M, consensus $565.76M

TIPRANKS
·
Jan 12

BRIEF-Veracyte Outlook FY Revenue Growth 16%

Reuters
·
Jan 12

Veracyte Projects 2026 Revenue Growth of Up to 13% and Adjusted EBITDA Margin of 25%

Reuters
·
Jan 12

Veracyte Outlook FY Revenue USD 515-517 Million

THOMSON REUTERS
·
Jan 12